Advisor Partners LLC Lannett CO Inc Transaction History

Advisor Partners LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 12, 2021	SELL	$4.17 - $5.74 $46,653 - $64,219	-11,188 Closed	0 $0
Q1 2021 Jun 01, 2021	BUY	$5.28 - $9.64 $2,914 - $5,321	552 Added 5.19%	11,188 $59,000
Q4 2020 Feb 17, 2021	SELL	$5.75 - $7.13 $1,500 - $1,860	-261 Reduced 2.4%	10,636 $69,000
Q3 2020 Nov 19, 2020	SELL	$4.9 - $7.12 $12,980 - $18,860	-2,649 Reduced 19.56%	10,897 $67,000
Q2 2020 Aug 13, 2020	SELL	$6.43 - $9.86 $11,477 - $17,600	-1,785 Reduced 11.64%	13,546 $98,000
Q1 2020 May 15, 2020	BUY	$6.36 - $10.05 $11,886 - $18,783	1,869 Added 13.88%	15,331 $106,000
Q4 2019 Jan 24, 2020	BUY	$8.49 - $12.81 $9,194 - $13,873	1,083 Added 8.75%	13,462 $126,000
Q3 2019 Oct 16, 2019	BUY	$5.58 - $14.47 $1,601 - $4,152	287 Added 2.37%	12,379 $139,000
Q2 2019 Jul 26, 2019	SELL	$5.22 - $9.08 $2,714 - $4,721	-520 Reduced 4.12%	12,092 $73,000
Q1 2019 Apr 23, 2019	BUY	$5.35 - $9.82 $2,894 - $5,312	541 Added 4.48%	12,612 $99,000
Q4 2018 Jan 29, 2019	BUY	$3.43 - $6.19 $41,403 - $74,719	12,071 New	12,071 $60,000

Ticker LCI
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,960,000
Market Cap $1.29M
Description
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...

Get notified when there are updates to the investment portfolio of Advisor Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Advisor Partners LLC with notifications on news.